Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
HF Escobar-Morreale - Nature Reviews Endocrinology, 2018 - nature.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …
Polycystic ovary syndrome
DA Ehrmann - New England Journal of Medicine, 2005 - Mass Medical Soc
The polycystic ovary syndrome is one of the most common hormonal disorders affecting
women. It has multiple components—reproductive, metabolic, and cardiovascular—with …
women. It has multiple components—reproductive, metabolic, and cardiovascular—with …
[HTML][HTML] Day–night pattern of sudden death in obstructive sleep apnea
AS Gami, DE Howard, EJ Olson… - New England Journal of …, 2005 - Mass Medical Soc
Background The risk of sudden death from cardiac causes in the general population peaks
from 6 am to noon and has a nadir from midnight to 6 am Obstructive sleep apnea is highly …
from 6 am to noon and has a nadir from midnight to 6 am Obstructive sleep apnea is highly …
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review
Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2
diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin …
diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin …
Polycystic ovarian syndrome: diagnosis and management
MT Sheehan - Clinical Medicine & Research, 2004 - Marshfield Clinic
Polycystic ovarian syndrome (PCOS) affects 4% to 12% of women of reproductive age. The
lack of well-defined diagnostic criteria makes identification of this common disease …
lack of well-defined diagnostic criteria makes identification of this common disease …
Metformin for the treatment of the polycystic ovary syndrome
JE Nestler - New England Journal of Medicine, 2008 - Mass Medical Soc
A 23-year-old woman with the polycystic ovary syndrome presents for evaluation and
possible treatment. She has a family history of diabetes, is obese, and has impaired glucose …
possible treatment. She has a family history of diabetes, is obese, and has impaired glucose …
Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications
E Diamanti-Kandarakis - Expert Reviews in molecular medicine, 2008 - cambridge.org
Polycystic ovarian syndrome (PCOS) is universally recognised as the commonest
endocrinopathy of women. The definition and the aetiological hypotheses of PCOS are …
endocrinopathy of women. The definition and the aetiological hypotheses of PCOS are …
The importance of estradiol for body weight regulation in women
P Vigil, J Meléndez, G Petkovic… - Frontiers in …, 2022 - frontiersin.org
Obesity in women of reproductive age has a number of adverse metabolic effects, including
Type II Diabetes (T2D), dyslipidemia, and cardiovascular disease. It is associated with …
Type II Diabetes (T2D), dyslipidemia, and cardiovascular disease. It is associated with …
Combined lifestyle and herbal medicine in overweight women with polycystic ovary syndrome (PCOS): a randomized controlled trial
Polycystic ovary syndrome (PCOS) is a common, complex reproductive endocrinopathy
characterized by menstrual irregularities, hyperandrogenism and polycystic ovaries …
characterized by menstrual irregularities, hyperandrogenism and polycystic ovaries …
Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: A further help for human reproduction and beyond
F Facchinetti, M Appetecchia, C Aragona… - Expert opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction: This Experts' opinion provides an updated scientific support to
gynecologists, obstetricians, endocrinologists, nutritionists, neurologists and general …
gynecologists, obstetricians, endocrinologists, nutritionists, neurologists and general …